These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19850771)
1. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Gaston RS Clin J Am Soc Nephrol; 2009 Dec; 4(12):2029-34. PubMed ID: 19850771 [TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Issa N; Kukla A; Ibrahim HN Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509 [TBL] [Abstract][Full Text] [Related]
12. Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors. Nashan B Transpl Int; 2004 Jul; 17(6):279-85. PubMed ID: 15221123 [TBL] [Abstract][Full Text] [Related]
13. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients. Martínez-Mier G; Méndez-López MT; Estrada-Oros J; Budar-Fernandez LF; Soto-González JI; Méndez-Machado GF; Viñas Dozal JC Arch Med Res; 2006 Jul; 37(5):635-8. PubMed ID: 16740435 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitor-free immunosuppression in kidney transplantation. Guerra G; Srinivas TR; Meier-Kriesche HU Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419 [TBL] [Abstract][Full Text] [Related]
15. Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience. Weber T; Abendroth D; Schelzig H Transpl Int; 2005 Feb; 18(2):151-6. PubMed ID: 15691266 [TBL] [Abstract][Full Text] [Related]
16. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors? Nashan B Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616 [TBL] [Abstract][Full Text] [Related]
18. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517 [TBL] [Abstract][Full Text] [Related]
19. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Liptak P; Ivanyi B Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468 [TBL] [Abstract][Full Text] [Related]
20. Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation. Golshayan D; Pascual M Transpl Immunol; 2008 Nov; 20(1-2):21-8. PubMed ID: 18775494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]